NCT01272037 2026-03-18
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
14 trialsNCT01349322 2026-03-05
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Radiation Therapy Oncology Group
Phase 3 Active not recruiting
NCT00757302 2025-12-22
Intraoperative Gamma Camera for Breast Cancer Surgery
University Hospital, Strasbourg, France
Phase 3 Completed
NCT00769379 2025-06-12
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
National Cancer Institute (NCI)
Phase 3 Completed
NCT01905046 2025-04-13
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT04722692 2023-08-03
SENTINOT_2
Uppsala University
Phase 3 Recruiting
NCT01357772 2023-07-17
TAM-01
Ente Ospedaliero Ospedali Galliera
Phase 3 Active not recruiting
NCT00003857 2022-05-25
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Radiation Therapy Oncology Group
Phase 3 Completed
NCT02961790 2020-01-18
Oxybutynin Chloride in Managing Hot Flashes
Academic and Community Cancer Research United
Phase 3 Completed
NCT04046159 2019-08-06
Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
National Taiwan University Hospital
Phase 3 Unknown
NCT01112254 2016-01-26
IRCIS
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Completed
NCT01185132 2014-06-26
2009-APBI
Rocky Mountain Cancer Centers
Phase 3 Recruiting
NCT00324714 2012-11-29
Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS
ETOP IBCSG Partners Foundation
Phase 3 Withdrawn
NCT00002920 2012-10-31
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
SWOG Cancer Research Network
Phase 3 Completed